We are live on
!
Find out more
DBG
De Burlo Group Portfolio holdings
AUM
$441M
1-Year Est. Return
21.21%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$478M
AUM Growth
-$27.4M
(-5.4%)
Cap. Flow
-$37.3M
Cap. Flow
% of AUM
-7.8%
Top 10 Holdings %
Top 10 Hldgs %
29.76%
Holding
113
New
12
Increased
22
Reduced
49
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$7.58M |
| 2 |
MBLY
Mobileye N.V.
MBLY
|
+$4.9M |
| 3 |
Ambarella
AMBA
|
+$4.73M |
| 4 |
Bright Horizons
BFAM
|
+$4.27M |
| 5 |
Tractor Supply
TSCO
|
+$3.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$14.5M |
| 2 |
Atmos Energy
ATO
|
+$5.49M |
| 3 |
Chubb
CB
|
+$4.86M |
| 4 |
Allstate
ALL
|
+$4.51M |
| 5 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$4.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.56% |
| 2 | Technology | 21.78% |
| 3 | Consumer Discretionary | 18.9% |
| 4 | Industrials | 8.09% |
| 5 | Financials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.79T
| $26M | 5.45% |
830,752
-96,928
| -10% | -$3.1M |
|
2
Gilead Sciences
GILD
$166B
| $18.6M | 3.88% |
158,518
-700
| -0.4% | -$76.5K |
|
3
McKesson
MCK
$97.6B
| $15.1M | 3.17% |
67,325
+500
| +0.7% | +$116K |
|
4
Illumina
ILMN
$27.9B
| $14M | 2.93% |
65,895
-8,532
| -11% | -$1.67M |
|
5
NXP Semiconductors
NXPI
$68.6B
| $13.6M | 2.86% |
139,000
+12,950
| +10% | +$1.33M |
|
6
Marriott International
MAR
$96.8B
| $11.7M | 2.44% |
157,000
| – | – |
|
7
Henry Schein
HSIC
$9.87B
| $11.5M | 2.4% |
206,091
+382
| +0.2% | +$21.1K |
|
8
Nike
NKE
$64.2B
| $11.3M | 2.37% |
209,900
| – | – |
|
|
SRCL
9
DELISTED
Stericycle Inc
SRCL
| $10.3M | 2.15% |
76,751
+150
| +0.2% | +$20.6K |
|
|
SIAL
10
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $10M | 2.1% |
71,850
-30,100
| -30% | -$4.18M |
|
11
Magna International
MGA
$18.2B
| $9.83M | 2.06% |
175,200
+32,400
| +23% | +$1.8M |
|
12
Cencora
COR
$59.4B
| $9.71M | 2.03% |
91,300
-14,100
| -13% | -$1.59M |
|
13
Ulta Beauty
ULTA
$20.9B
| $9.52M | 1.99% |
61,670
+300
| +0.5% | +$46.1K |
|
|
ALXN
14
DELISTED
Alexion Pharmaceuticals
ALXN
| $9.51M | 1.99% |
52,595
-14,950
| -22% | -$2.58M |
|
15
Biogen
BIIB
$30.1B
| $9.01M | 1.89% |
22,315
-2,100
| -9% | -$843K |
|
16
Mohawk Industries
MHK
$6.65B
| $8.76M | 1.83% |
45,880
-50
| -0.1% | -$9.25K |
|
17
Reinsurance Group of America
RGA
$15.9B
| $8.69M | 1.82% |
91,600
+15,500
| +20% | +$1.46M |
|
18
Aptiv
APTV
$12.2B
| $8.55M | 1.79% |
100,450
+13,600
| +16% | +$1.16M |
|
19
CVS Health
CVS
$137B
| $8.52M | 1.78% |
81,256
+8,300
| +11% | +$848K |
|
20
Perrigo
PRGO
$1.47B
| $8.43M | 1.76% |
45,600
+17,200
| +61% | +$3.28M |
|
21
Quest Diagnostics
DGX
$23.1B
| $8.39M | 1.76% |
115,700
+100
| +0.1% | +$7.38K |
|
|
22
Palo Alto Networks
PANW
$292B
| $8.26M | 1.73% |
+283,800
| New | +$7.58M |
|
23
AbbVie
ABBV
$448B
| $7.75M | 1.62% |
115,410
+8,823
| +8% | +$576K |
|
24
Broadcom
AVGO
$1.82T
| $7.74M | 1.62% |
582,500
+31,000
| +6% | +$406K |
|
25
Salesforce
CRM
$140B
| $7.66M | 1.6% |
110,050
+8,800
| +9% | +$627K |
|
Similar funds
ECA
DWML
BOA
PLU
CPW
AWM
CAAM
SCP
De Burlo Group's Q2 2015 Portfolio in Review
As of Q2 2015, De Burlo Group held 113 positions worth $478M, down 5.4% from $505M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
De Burlo Group withdrew a net $37.3M in Q2 2015, closing 9 positions and reducing 49 holdings. Its most notable exit was Allergan plc, an estimated $14.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, De Burlo Group opened a new position in Palo Alto Networks worth $8.26M.
- De Burlo Group's largest Q2 2015 buy was Palo Alto Networks: 283,800 shares worth $8.26M.
- De Burlo Group added most to Perrigo in Q2 2015, an estimated $3.28M increase.
- De Burlo Group's biggest Q2 2015 reduction was Atmos Energy, cutting an estimated $5.49M.
- De Burlo Group fully exited Allergan plc in Q2 2015, selling an estimated $14.5M.
- De Burlo Group's ten largest holdings make up 30% of its $478M portfolio in Q2 2015.
- De Burlo Group opened 12 new positions and closed 9 in Q2 2015.
- De Burlo Group's portfolio value fell 5.4% quarter-over-quarter to $478M.
Based on De Burlo Group's 13F filing for Q2 2015, filed 7 Aug 2015.